Implications of genetic risk factors in breast cancer: Culprit genes and associated malignancies;Comment prendre en compte le risque génétique de cancer du sein? Gènes impliqués et risques tumoraux associés

Bulletin de l'Academie Nationale de Medecine

Volumn 193, Issue 9, 2009, Pages 2063-2085

  Stoppa Lyonnet, Dominique ^a,b   Buecher, Bruno ^a,d   Gauthier Villars, Marion ^a   Houdayer, Claude ^a,c   De Pauw, Antoine ^a   De La Rochefordiere, Anne ^e   This, Pascale ^a   Asselain, Bernard ^a,f,g   Andreieu, Nadine ^a,f,g  

^a INSTITUT CURIE   (France)

^b INSTITUT CURIE   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e Departement de Radiotherapie   (France)

^f INSERM   (France)

^g PSL RESEARCH UNIVERSITY   (France)

Author keywords

BRCA1. Genes; BRCA2. Genes TP53. PTEN. Genome; Genes; Human. Breast Neoplasms. Ovarian Noeplasms. Risk Factors

Indexed keywords

EID: 77954469380     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)32379-9     Document Type: Review

References (54)

1. CLAUS E.B., RISCH N., THOMPSON WD -Genetic analysis of breast cancer in the cancer and steroid hormone study. Am. J. Hum Genet., 1991, 48(2), 232-42.
2. HALL J.M., LEE M.K., NEWMAN B., MORROW J.E., ANDERSON L.A., HUEY B. et al. -Linkage of early-onset familial breast cancer to chromosome 17q21. Science, 1990, 250 (4988), 1684-9.
3. MIKI Y., SWENSEN J., SHATTUCK-EIDENS D., FUTREAL P.A., HARSHMAN K., TAVTIGIAN S. et al. - A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 1994, 266 (5182), 66-71. (Pubitemid 24345325)
4. NAROD S.A., FEUNTEUN J., LYNCH H.T., WATSON P., CONWAY T., LYNCH J. et al. - Familial breast-ovarian cancer locus on chromosome 17q12-q23. Lancet, 1991, 338 (8759), 82-3.
5. WOOSTER R., BIGNELL G., LANCASTER J., SWIFT S., SEAL S., MANGION J. et al. - Identification of the breast cancer susceptibility gene BRCA2. Nature, 1995, 378(6559), 789-92.
6. SMITH S.A., EASTON D.F., EVANS D.G., PONDER B.A. - Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat. Genet. 1992, 2(2), 128-31.
7. GUDMUNDSDOTTIR K., ASHWORTH A. -The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability. Oncogene. 2006 Sep 25, 25(43), 5864-74.
8. MONTEIRO A.N. - BRCA1: the enigma of tissue-specific tumor development. Trends Genet. 2003 Jun, 19(6), 312-5.
9. GOLDGAR D.E., EASTON D.F., DEFFENBAUGH A.M., MONTEIRO A.N., TAVTIGIAN S.V., COUCH F.J. - Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2. Am. J. Hum. Genet., 2004, Oct., 75(4). 535-44.
10. FORD D., EASTON D.F., STRATTON M., NAROD S., GOLDGAR D., DEVILEE P. et al. - Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am. J. Hum. Genet., 1998, 62(3), 676-89.
11. CASILLI F., TOURNER I., SINILKOVA O.M., COULET F., SOUBRER F., HOUDAYER C. et al. -The contribution of germline rearrangements to the spectrum of BRCA2 mutations. J. Med. Genet., 2006 Sep., 43(9), e49.
12. ANTONIOU A.C., PHAROAH P.D., MCMULLAN G., DAY N.E., PONDER B.A., EASTON D. -Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet. Epidemiol., 2001, 21(1), 1-18. (Pubitemid 32619211)
13. ANTONIOU A.C., PHAROAH P.D., MCMULLAN G., DAY N.E., STRATTON M.R., PETO J. et al. - A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br. J. Cancer, 2002, 86(1), 76-83. (Pubitemid 34146344)
14. ANTONIOU A., PHAROAH P.D., NAROD S., RISCH H.A., EYFJORD J.E., HOPPER J.L. et al. -Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J. Hum. Genet., 2003 May, 72(5), 1117-30.
15. METCALFE K., LYNCH H.T., GHADIRIAN P., TUNG N., OLIVOTTO I., WARNER E. et al. -Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J. Clin. Oncol., 2004 Jun 15,22(12), 2328-35.
16. TAI YC., DOMCHEK S., PARMIGIANI G., CHEN S. - Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. J. Natl Cancer Inst., 2007 Dec 5, 99(23), 1811-4.
17. THOMPSON D, EASTON D. -Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am. J. Hum. Genet., 2001, 68(2), 410-9.
18. EISINGER F., BRESSAC B., CASTAIGNE D., COTTU P.H., LANSAC J., LEFRANC J.P. et al. -Identification et prise en charge des prédispositions héréditaires aux cancers du sein et de l'ovaire (mise à jour 2004)]. Bull Cancer, 2004 Mar., 91(3), 219-37.
19. BCLC BCLC - CANCER RISKS IN BRCA2 MUTATION CARRERS. J. Natl. Cancer Inst., 1999, 91(15), 1310-6.
20. THOMPSON D., EASTON D.F. - Cancer Incidence in BRCA1 mutation carriers. J. Natl. Cancer Inst., 2002 Sep 18, 94 (18), 1358-65.
21. KING M.C, MARKS J.H., MANDELL J.B. - Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science, 2003 Oct 24, 302(5645), 643-6.
22. SIMCHONI S., FRIEDMAN E., KAUFMAN B., GERSHONI-BARUCH R., ORRURTREGER A., KEDARBARNES I. et al. -Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population. Proc Natl. Acad Sci., USA. 2006 Mar 7,103(10), 3770-4.
23. REBBECH T.R., LYNCH H.T., NEUHAUSEN S.L., NAROD S.A., VAN'T VEER L., GARBER J.E. et al. - Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl. J. Med., 2002 May 23, 346(21), 1616-22.
24. CHANG-CLAUDE J., ANDREU N., ROOKUS M., BROHET R., ANTONIOU A.C., PEOCK S. et al. -Age at menarche and menopause and breast cancer risk in the International BRCA1/2 Carrier Cohort Study. Cancer Epidemiol Biomarkers Prev.,2001 Apr., 16(4), 740-6.
25. REBBECK T.R., LEVIN A.M., EISEN A., SNYDER C., WATSON P., CANNON-ALBRIGHT L. et al. -Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J. Natl. Cancer Inst., 1999, 97(77), 1475-9.
26. ANDREU N., GOLDGAR D.E., EASTON D.F., ROOKUS M., BROHET R., ANTONIOU A.C. et al. -Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS). J. Natl. Cancer Inst., 2006 Apr 19, 98(8), 535-44.
27. ANDREU N., EASTON D.F., CHANG-CLAUDE J., ROOKUS M.A., BROHET R., CARDIS E. et al -Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group. J. Clin. Oncol., 2006 Jul. 20, 24(21), 3361-6.
28. BROHET R.M., GOLDGAR D.E., EASTON D.F., ANTONIOU A.C., ANDREU N., CHANG-CLAUDE J. et al. -Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group. J. Clin. Oncol., 2007 Sep 1, 25(25), 3831-6.
29. GOLDSTEIN A.M., DONDON M.G., ANDREU N. -Unconditional analyses can increase efficiency in assessing gene-environment interaction of the case-combined-control design. Int. J. Epidemiol, 2006 Aug., 35(4), 1067-73.
30. CHENEVLX-TRENCH G., MILNE R.L., ANTONIOU A.C., COUCH F.J., EASTON D.F., GOLDGAR D.E. -An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA). Breast Cancer Res., 2007, 9(2), 104.
31. ANTONIOU A.C., SINILNKOVA O.M., SIMARD J., LEONE M., DUMONT M., NEUHAUSEN S.L. et al. - RAD51135G->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Am. J. Hum. Genet., 2007 Dec., 81(6), 1186-200.
32. ANTONIOU A.C., SPURDLE A.B., SINELNIKOVA O.M., HEALEY S., POOLEY K.A., SCHMUTZLER R.K. et al. - Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am. J. Hum. Genet., 2008 Apr., 82(4), 937-48.
33. CHOMPRET A., BRUG̀RES L., RONSIN M., GARDES M., DESSARPS-FRHCHEY F., ABEL A. et al. -P53 germline mutations in childhood cancers and cancer risk for carrier individuals. Br. J. Cancer, 2000, 82(12), 1932-7.
34. BELL D.W., VARLEY J.M., SZYDLO T.E., KANG D.H., WAHRER D.C., SHANNON K.E. et al.-Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science, 1999, 286(5449), 2528-31.
35. BOUGEARD G., LIMACHER J.M., MARTIN C., CHARBONNER F., KJLLIAN A., DELATTRE O. et al. - Detection of 11 germline inactivating TP53 mutations and absence of TP63 and HCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndrome J. Med. Genet.. 2001 Apr., 38(4), 253-7.
36. FREBOURG T., ABEL A., BONAITI-PELLE C., BRUG̀RES L., BERTHET P., BRESSAC-DE PAELLERETS B. et al -[Li-Fraumeni syndrome: update, new data and guidelines for clinical management]. Bull. Cancer, 2001, 88(6), 581-7.
37. LONGY M. - [Cowden disease and the PTEN gene: a successfully clinical and biological combined approach]. Bull. Cancer, 2001, 88(12), 1153-8.
38. GIARDELLO F.M., TRIMBATH XD. - Peutz-Jeghers syndrome and management recommendations. Clin. Gastroenterol. Hepatol., 2006 Apr., 4(4), 408-15.
39. GIARDELLO F.M., BRENSINGER J.D., TERSMETTE A.C., GOODMAN S.N., PETERSEN G.M., BOOKER S.V. ET al. - Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology. 2000, 119(6), 1447-53.
40. OLSCHWANO S., BOISSON C., THOMAS G. - Peutz-Jeghers families unlinked to STK11/LKB1 gene mutations are highly predisposed to primitive biliary adenocarcinoma. J. Med. Genet., 2001 Jun, 38(6), 356-60.
41. PHAROAH P.D., GUILFORD P., CALDAS C - Incidence of gastric cancer and breast cancer in CDHl (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology, 2001 Dec., 121(6), 1348-53.
42. BLAIR V., MARTIN I., SHAW D., WINSHTP I., KERR D., ARNOLD J. et al. - Hereditary diffuse gastric cancer: diagnosis and management. Clin. Gastroenterol. Hepatol., 2006, Mar. 4(3), 262-75.
43. MASCIARI S., LARSSON N., SENZ J., BOYD N., KAURAH P., KANDELL M.J. et. al. - Germline E-cadherin mutations in familial lobular breast cancer. J. Med Genet., 2007 Nov., 44(11), 726-31.
44. STEWART G.S., MASER R.S., STANKOVIC T., BRESSAN D.A., KAPLAN M.I., JASPERS N.G. et. al. -The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxiatelangiectasia-like disorder. Cell, 1999, 99(6), 577-87.
45. GEOFFROY-PEREZ B., JANIN N., OSSIAN K., LAUGE A., CROQUETTE M.F., GRISCELLI C et al. -Cancer risk in heterozygotes for ataxia-telangiectasia. Int. J. Cancer, 2001, 93(2), 288-93.
46. RENWICK A., THOMPSON D., SEAL S., KELLY P., CHAGTAI T., AHMED M. et al. - ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat. Genet, 2006 Aug., 38(8), 873-5.
47. CORTEZ D., WANG Y., QIN J., ELLEDGE S.J. - Requirement of ATM-dependent phosphorylation of brcal in the DNA damage response to double-strand breaks. Science, 1999, 286(5442), 1162-6.
48. HOWLETT N.G., TANIGUCHI T., OLSON S., Cox B., WAISFISZ Q., DE DESMULDERS C. et al. -Biallelic inactivation of BRCA2 in Fanconi anemia. Science. 2002 Jul. 26, 297(5581), 606-9. (Pubitemid 34815345)
49. SEAL S., THOMPSON D., RENWICK A., ELLIOTT A., KELLY P., BARFOOT R. et al. -Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat. Genet., 2006 Nov., 38(11), 1239-41.
50. WEISCHER M., BOJOSEN S.E., ELLERVIK C., TYBJAERG-HANSEN A., NORDESTGAARD B.G. -CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls. J. Clin. Oncol., 2008 Feb., 1, 26(4), 542-8.
51. DUNNING A.M., HEALEY C.S., PHAROAH P.D., TEARE M.D., PONDER B.A., EASTON D.F. - A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev., 1999, 8(10), 843-54.
52. EASTON D.F., POOLEY K.A., DUNNING A.M., PHAROAH P.D., THOMPSON D., BALUNGER D.G. et al -Genome-wide association study identifies novel breast cancer susceptibility loci. Nature, 2007 May 27.
53. 7th Biennial meeting of the Leeds Castle Polyposis Group (LCPG) and the 9th annual meeting of the International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Noordwijk, the Netherlands, 4-7 June 1997. Abstracts. Int. J. Colorectal. Dis., 1997, 12(6), 344-66.
54. FORD D., EASTON D.F., BISHOP D.T., NAROD S.A., GOLDGAR D.E. - Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet, 1994, 343(8899), 692-5.